Ownership history in CM Management, LLC · 6 quarters on record
This page tracks every 13F SEC filing in which CM Management, LLC reported a position in RIGEL PHARMACEUTICALS INC (RIGL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 225,000 | — | 0% | 8.12% | $9.6M | $42.83 |
| 2025 Q3 | REDUCED | 225,000 | -25,000 | -10.0% | 5.31% | $6.4M | $28.33 |
| 2025 Q2 | UNCHANGED | 250,000 | — | 0% | 4.26% | $4.7M | $18.73 |
| 2025 Q1 | ADDED | 250,000 | +7,500 | +3.1% | 4.52% | $4.5M | $17.99 |
| 2024 Q4 | REDUCED | 242,500 | -47,500 | -16.4% | 3.64% | $4.1M | $16.82 |
| 2024 Q3 | INITIATED | 290,000 | — | — | 3.74% | $4.7M | $16.18 |
As of 2025 Q4 — sorted by position size